Thought Leadership

Quality Executive Partners, Inc. keeps you up-to-date and diving deep into the needs and challenges that pharmaceutical companies face today.

Christine Feaster
Why an Inadequate Form 483 Response Can Turn an Inspection Problem Into an Enforcement Problem
:
Christine Feaster
Clinical Success Is Not Commercial Readiness
:
The Radiopharmaceutical Manufacturing Challenge
Christine Feaster
Reading Between the Lines
:
What FDA Foreign Inspections in Europe and Asia Are Really Telling Us
Christine Feaster
FDA Warning Letters Are Accelerating
:
And They Keep Telling the Same Story